Research Topics
Genomes and Genes | N J BrownSummaryAffiliation: Vanderbilt University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykininN J Brown
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
Thromb Haemost 77:522-5. 1997..Bradykinin had no effect on PAI-1 antigen levels. These in vivo data suggest that infusion of bradykinin results in an increase in circulating t-PA levels without an effect on PAI-1...
The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal diseaseNancy J Brown
Divisions of Clinical Pharmacology and Cardiovascular Medicine, Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA
Semin Nephrol 22:399-406. 2002..Interruption of the RAAS decreases both PAI-1 expression and fibrosis in animal models. These findings have implications for the clinical management of renal disease...
ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over timeNancy J Brown
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
Hypertension 40:859-65. 2002....
Aldosterone and PAI-1: implications for renal injuryNancy J Brown
Deaprtment of Medicine, Vanderbilt University, Nashville, TN, USA
J Nephrol 15:230-5. 2002..Aldosterone receptor antagonism decreases both PAI-1 expression and fibrosis in animal models. These findings have implications for the clinical management of cardiovascular and renal disease...
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivoN J Brown
Departments of Medicine and Pharmacology, Pathology, and Radiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Kidney Int 58:1219-27. 2000....
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 productionN J Brown
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232 6602, USA
J Clin Endocrinol Metab 85:336-44. 2000..Taken together, these data support the hypothesis that aldosterone modulates the effect of Ang II on PAI-1 expression in vitro and in vivo in humans...
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humansN J Brown
Department of Medicine, Vanderbilt University Medical Center, Nashville Veterans Administration Medical Center, Nashville, TN, USA
Hypertension 34:285-90. 1999..Further studies are needed to address the mechanism for the contrasting effects of these 2 classes of drugs on fibrinolysis and to define the clinical significance of these differences...
Bradykinin stimulates tissue plasminogen activator release in human vasculatureN J Brown
Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville Veterans Administration Medical Center, Nashville, TN, USA
Hypertension 33:1431-5. 1999..These data demonstrate that bradykinin stimulates tPA release in the human vasculature...
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1N J Brown
Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, Tenn 37232 6602, USA
Hypertension 32:965-71. 1998..The data suggest that ACE inhibition has the potential to reduce the incidence of thrombotic cardiovascular events by blunting the morning peak in PAI-1...
Recurrent angiotensin-converting enzyme inhibitor--associated angioedemaN J Brown
Department of Medicine, Vanderbilt University, Nashville, Tenn 37232 6602, USA
JAMA 278:232-3. 1997..Angiotensin-converting enzyme (ACE) inhibitors are associated with an increased risk of angioedema, but the risk of recurrent angioedema if treatment is continued is not known...
Angiotensin-converting enzyme inhibitorsN J Brown
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn 37232 6602, USA
Circulation 97:1411-20. 1998....
Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian populationJ A Schoenhard
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical School, Nashville, TN, USA
Hum Genet 124:479-88. 2008....
The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistanceM M Pretorius
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Clin Pharmacol Ther 83:122-9. 2008..038) or during bradykinin (P=0.03). Increased SBP or vascular resistance may contribute to increased left ventricular mass reported previously in individuals with the BE1+9/+9 genotype...
Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiencyN J Brown
Vanderbilt University Medical Center, Nashville, Tennessee 37232 6602, USA
Kidney Int 72:72-81. 2007..We conclude that Ang II stimulates PAI-1 expression in part through the AT(1b) receptor in the kidney and liver. Further, norepinephrine induces PAI-1 expression in vivo with AT(1a) receptor deficiency modulating the effect...
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibitionK Kaikita
Department of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA
Circulation 104:839-44. 2001..Direct inhibition of vascular PAI-1 activity may provide a new therapeutic strategy for the prevention of arteriosclerotic cardiovascular disease...
A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levelsJ H Moore
Program in Human Genetics, Department of Molecular Physiology and Biophysics, 519 Light Hall, Vanderbilt University Medical School, Nashville, TN 37232 0700, USA
Clin Genet 62:74-9. 2002....
Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigenN J Brown
Divisions of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
Arterioscler Thromb Vasc Biol 21:1071-7. 2001..31, P=0.014) or low (R(2)=0.37, P=0.006) salt intake. This study identifies an important gene-by-environment interaction that may influence cardiovascular morbidity and the response to pharmacological therapies that interrupt the RAAS...
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearmT Wilsdorf
Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA
Hypertension 37:1136-40. 2001..62 for Ang-(1-7) effect]. These data do not support a role of Ang-(1-7), given at supraphysiological doses, in the regulation of human peripheral vascular resistance or fibrinolysis...
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injuryJ Ma
Division of Pediatric Nephrology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee 37232 6602, USA
Kidney Int 69:1064-72. 2006..05). Aldosterone induced cardiac hypertrophy but not fibrosis in WT and PAI-1(-/-) mice. PAI-1 contributes to aldosterone-induced glomerular injury...
Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variantJ V Gainer
Vanderbilt University Medical Center, Division of Clinical Pharmacology, Nashville, TN, USA
Biochem Mol Biol Int 43:227-31. 1997..05 +/- 0.01) and demonstrates a significantly lower frequency in African Americans compared with Caucasians (0.05 vs. 0.25, respectively, chi 2 = 30.7, p < < 0.001, 1 df)...
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemiaJ S Williams
Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
J Hum Hypertens 20:129-36. 2006..2%, a rate that might lead to excessive false positives with random screening in comparable populations. Hyperaldosteronism, when present, is responsive to sodium restriction...
The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphismsJ H Moore
Program in Human Genetics, Department of Molecular Physiology and Biophysics, 519 Light Hall, Vanderbilt University Medical School, Nashville, TN 37232 0700, USA
Clin Genet 62:53-9. 2002..This study supports the idea that interactions between the fibrinolytic and renin-angiotensin systems play an important role in the genetic architecture of plasma t-PA and PAI-1...
Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trialJ M Balaguer
Department of Cardiac Surgery, Vanderbilt University Medical School, Nashville, Tennessee, USA
Clin Pharmacol Ther 93:326-34. 2013..These data suggest that endogenous bradykinin contributes to t-PA generation in patients undergoing CPB, but that additional effects on plasmin generation contribute to decreased D-dimer concentrations during EACA treatment...
Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypassF T Billings
Department of Anesthesiology, Vanderbilt University Medical School, Nashville, Tennessee, USA
Clin Pharmacol Ther 91:1065-73. 2012..By contrast, neither ACE inhibition nor ARB affected the inflammatory response. ACE inhibitors and ARBs may be safely continued until the day of surgery...
Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic miceM Eren
Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232 6300, USA
J Thromb Haemost 1:2389-96. 2003..9 kb promoter...
Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assayL J Murphey
Division of Clinical Pharmacology, Veterans Affairs Medical Center, Nashville, Tennessee 37232-6602, USA
Anal Biochem 292:87-93. 2001..This assay provides the first accurate and precise method using MS to quantify BK1-5 in human blood as a marker for the production of systemic bradykinin in humans...
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine isletsJ M Luther
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, 2200 Pierce Ave, 560 RRB, Nashville, TN 37232 6602, USA
Diabetologia 54:2152-63. 2011..Aldosterone concentrations increase in obesity and predict the onset of diabetes. We investigated the effects of aldosterone on glucose homeostasis and insulin secretion in vivo and in vitro...
Possible medication errors in home healthcare patientsS Meredith
Department of Preventive Medicine, Division of Pharmacoepidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
J Am Geriatr Soc 49:719-24. 2001..More-effective methods are needed to improve medication use in this vulnerable population...
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant useJ B Byrd
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
Allergy 65:1381-7. 2010..One study has reported an increased incidence of ACE inhibitor-associated angioedema among transplant patients compared to published rates, while several case series report angioedema in patients taking specific immunosuppressant agents...
Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-AmericansJ V Gainer
Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Am J Hypertens 13:1268-73. 2000..75 v. 0.62, P = .009). Thus, this B2 receptor promoter polymorphism may represent a susceptibility marker for essential hypertension in African-Americans...
A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypassMias Pretorius
Veterans Affairs Medical Center and Department of Anesthesiology, Vanderbilt University School of Medicine, 560 Robinson Research Building, Nashville, TN 37232, USA
Clin Pharmacol Ther 78:477-85. 2005..This study tests the primary hypothesis that blocking the bradykinin B(2) receptor would attenuate protamine-related hypotension...
Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertensionBindu Chamarthi
Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, Massachusetts 02115, USA
J Clin Endocrinol Metab 92:1340-6. 2007..Emerging evidence suggests a role for cortisol in essential hypertension, and preliminary reports indicate that urinary free cortisol (UFC) may be an intermediate phenotype...
Ala92 type 2 deiodinase allele increases risk for the development of hypertensionOlga Gumieniak
Endocrinology, Diabetes, and Hypertension Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
Hypertension 49:461-6. 2007..These data support an important role for genetic variation in the hypothalamic-pituitary-thyroid pathway in influencing susceptibility to hypertension...
Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockadeJean Lefebvre
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
J Pharmacol Exp Ther 320:1261-7. 2007..HOE-140 augmented the heart rate response to chronic valsartan (P = 0.04). These data suggest that endogenous bradykinin does not contribute significantly to the blood pressure-lowering effect of valsartan through its B(2) receptor...
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanismJames M Luther
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
Hypertension 48:1050-7. 2006..In contrast, angiotensin II-induced oxidative stress, as measured by F(2)-isoprostanes, is mineralocorticoid receptor independent and may be pressor dependent...
Regression of existing glomerulosclerosis by inhibition of aldosteroneJean Claude Aldigier
Department of Pathology, Vanderbilt University Medical Center, 21st and Garland Avenue, Nashville, TN 37232-2561, USA
J Am Soc Nephrol 16:3306-14. 2005..It is concluded that inhibition of aldosterone by SP not only slows development of glomerulosclerosis but also induces regression in some rats of existing glomerulosclerosis...
Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humansLaine J Murphey
Department of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232-6602, USA
J Pharmacol Exp Ther 318:1287-92. 2006..By inhibiting thrombin-induced platelet aggregation without causing vasodilation, bradykinin 1-5 may provide a model for small molecule substrate-selective thrombin inhibitors...
Blood pressure reduction and tissue-type plasminogen activator releaseNancy J Brown
Hypertension 47:648-9. 2006
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibitionNancy J Brown
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
Hypertension 47:441-8. 2006..During angiotensin-converting enzyme inhibition, endogenous NO decreases plasminogen activator inhibitor-1 antigen and improves fibrinolytic balance in normotensive salt-replete subjects...
Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomesAbigail M Brown
Programs of Clinical and Translational Scientist Development and Biomedical Research Education and Training, Vanderbilt School of Medicine, Nashville, Tennessee 37232 6602, USA
Acad Med 83:969-75. 2008..The authors evaluate the impact of the VPSD and VCRS programs on early career outcomes of physician-scientists...
Association of a CYP4A11 variant and blood pressure in black menJames V Gainer
Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
J Am Soc Nephrol 19:1606-12. 2008..These data support a role for renal monooxygenases and 20-hydroxyeicosatetraenoic acid in the regulation of BP and renal function in men...
Milrinone use is associated with postoperative atrial fibrillation after cardiac surgeryGregory A Fleming
Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
Circulation 118:1619-25. 2008..Inotropic drugs are commonly used perioperatively to support ventricular function. This study tested the hypothesis that the use of inotropic drugs is associated with postoperative AF...
17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal womenMias Pretorius
Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, Tenn, USA
Hypertension 51:1190-6. 2008..17Beta-estradiol increases basal release of active t-PA in young postmenopausal women, consistent with enhanced vascular fibrinolytic function...
The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertensionCheryl L Laffer
Texas A and M Health Science Center College of Medicine, Temple, TX 76508, USA
Hypertension 51:767-72. 2008..We propose that genotype analyses with sufficient homozygous CC will establish definitive relationships among 20-HETE, salt sensitivity of blood pressure, and insulin resistance...
Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibitionGary P Van Guilder
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
Hypertension 51:454-9. 2008..In conclusion, the BDKRB2 BE1 polymorphism influences bradykinin type 2 receptor-mediated vasodilation during angiotensin-converting enzyme inhibition...
Aldosterone and vascular inflammationNancy J Brown
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-6602, USA
Hypertension 51:161-7. 2008
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedemaJames Brian Byrd
Department of Medicine, Vanderbilt University Medical School, Nashville, TN, USA
Hypertension 51:141-7. 2008..Environmental or genetic factors that reduce dipeptidyl peptidase IV activity may predispose individuals to angioedema...
A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1Scott M Williams
Center for Human Genetics Research, 519 Light Hall, Vanderbilt University Medical School, Nashville, TN 37232 0700, USA
Ethn Dis 17:492-7. 2007..We have initiated a large-scale population-based study to characterize the genetic architecture of plasma t-PA and PAI-1 in Blacks from Sunyani, Ghana...
Functional BSND variants in essential hypertensionSaba Sile
Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232 0275, USA
Am J Hypertens 20:1176-1182. 2007..Sodium chloride reabsorption in the thick ascending limb (TAL) is dependent in part on the chloride channel, ClC-Kb (encoded by CLCNKB), and its accessory subunit, barttin (encoded by BSND)...
Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypassMias Pretorius
Department of Anesthesiology, Vanderbilt University Medical School, Nashville, TN 37232, USA
Circulation 116:I1-7. 2007..This study tests the hypothesis that biomarkers predict the development of postoperative AF...
Aldosterone and end-organ damageAnnis M Marney
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 6602, USA
Clin Sci (Lond) 113:267-78. 2007....
The kallikrein-kinin system: current and future pharmacological targetsMarie Eve Moreau
Faculty of Pharmacy, University of Montreal, Canada
J Pharmacol Sci 99:6-38. 2005....
G protein-coupled receptor kinase 4 gene variants in human essential hypertensionRobin A Felder
Department of Pathology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA
Proc Natl Acad Sci U S A 99:3872-7. 2002..These findings provide a mechanism for the D(1) receptor coupling defect in the kidney and may explain the inability of the kidney to properly excrete sodium in genetic hypertension...
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1Li Jun Ma
Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Diabetes 53:336-46. 2004..Inhibition of PAI-1 might provide a novel anti-obesity and anti-insulin resistance treatment...
Loss of sodium modulation of plasma kinins in human hypertensionLaine J Murphey
Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
J Pharmacol Exp Ther 308:1046-52. 2004..With hypertension, these modulating effects are diminished or lost, supporting a role for both systems in the development/maintenance of hypertension...
Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular functionMarshall L Summar
Department of Pediatrics, Division of Medical Genetics, Vanderbilt University Medical Center, Nashville, Tenn 37232 6602, USA
Hypertension 43:186-91. 2004..943). These data indicate that a polymorphism in the gene encoding carbamoyl-phosphate synthetase 1 influences nitric oxide production as well as vascular smooth muscle reactivity...
Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypassMias Pretorius
Department of Anesthesiology, Vanderbilt University, Nashville, Tenn, USA
Circulation 108:3079-83. 2003..Because angiotensin II stimulates PAI-1 expression, we tested the hypothesis that preoperative angiotensin-converting enzyme (ACE) inhibition decreases PAI-1 expression after CABG...
Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensivesLaine J Murphey
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
Free Radic Biol Med 35:711-8. 2003..2 +/- 4.4 to 58.9 +/- 6.6 pg/ml, p=0.83). Acute Ang II infusion increases oxidative stress in vivo in hypertensive humans. The renin-angiotensin system may contribute to oxidative stress in human cardiovascular disease...
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1Pairunyar Sawathiparnich
Divisions of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6602, USA
J Clin Endocrinol Metab 88:3867-73. 2003..2 ng/ml (9.8, 28.6), P = 0.974 vs. baseline, P < 0.05 vs. candesartan, spironolactone or furosemide alone]. This study evidences an interactive effect of endogenous Ang II and aldosterone on PAI-1 production in humans...
Eplerenone: cardiovascular protectionNancy J Brown
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn 37232 6602, USA
Circulation 107:2512-8. 2003..This review provides an overview of the pharmacology, efficacy, and safety of a new, more selective aldosterone receptor antagonist, eplerenone, in the context of emerging concepts of the role of aldosterone in cardiovascular toxicity...
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykininMias Pretorius
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn 37232-6602, USA
Circulation 107:579-85. 2003..005). HOE 140 blocked these effects. There was no effect of enalaprilat or HOE 140 on the FBF or t-PA response to methacholine. CONCLUSION: ACE inhibition increases constitutive endothelial t-PA release through endogenous bradykinin...
Characterization of the CYP4A11 gene, a second CYP4A gene in humansAouatef Bellamine
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232 0146, USA
Arch Biochem Biophys 409:221-7. 2003..RT-PCR amplification of human kidney RNA followed by restriction fragment analysis showed that CYP4A11 is the predominant isoform expressed in kidney...
PAI-1 in human hypertension: relation to hypertensive groupsNadarajah Srikumar
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
Am J Hypertens 15:683-90. 2002..However, the data suggest that ALDO may be an important factor contributing to the variability of PAI-1 levels in individual hypertensive subjects...
Smoking impairs bradykinin-stimulated t-PA releaseMias Pretorius
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA
Hypertension 39:767-71. 2002..The vascular tissue plasminogen activator response to bradykinin, but not methacholine, is impaired in smokers. Stimulated tissue plasminogen activator release may be a more sensitive measure of endothelial function than vasodilation...
Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibitionKoichi Kaikita
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
J Mol Cell Cardiol 34:617-27. 2002..While PAI-1 deficiency protects against L -NAME-induced hypertension and perivascular fibrosis, t-PA deficiency does not exacerbate the vascular pathology or hypertension...
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validationChristopher S Coffey
Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294 0022, USA
BMC Bioinformatics 5:49. 2004..One advantage of the MDR method is that it provides an internal prediction error for validation. We summarize our use of this internal prediction error for model validation...
The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1Marvin T Nieman
Thromgen Inc, Ann Arbor, MI 48109-0640, USA
J Pharmacol Exp Ther 311:492-501. 2004..TH146 and MAP4-TH146 inhibit human and mouse platelet aggregation and mouse thrombosis. Analogs of RPPGF are model compounds to develop PAR1 activation antagonists as well as direct inhibitors to thrombin and factor VIIa...
Established and emerging plasma biomarkers in the prediction of first atherothrombotic eventsPaul M Ridker
Center for Cardiovascular Disease Prevention and the Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Mass 02115, USA
Circulation 109:IV6-19. 2004
Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in menMias Pretorius
Veterans Affairs Medical Center, Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN, USA
Arterioscler Thromb Vasc Biol 25:2435-40. 2005..Angiotensin-converting enzyme inhibition (ACEI) increases vascular tissue plasminogen activator (t-PA) release through endogenous bradykinin (BK). We tested the hypothesis that gender influences the effect of ACEI on t-PA release...
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balanceJi Ma
Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA
Hypertension 46:313-20. 2005....
Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertensionLorraine M King
Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA
Pharmacogenet Genomics 15:7-13. 2005..Confirmation of these findings in additional populations is warranted...
Aldosterone and end-organ damageNancy J Brown
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232 6602, USA
Curr Opin Nephrol Hypertens 14:235-41. 2005....
Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertensionJames V Gainer
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical School, Nashville, Tenn 37232 0146, USA
Circulation 111:63-9. 2005..We combined molecular and biochemical approaches to identify a functional variant of the CYP4A11 20-HETE synthase and determine its association with hypertensive status in 2 independent human populations...
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodelingAlec D Weisberg
Department of Medicine, Divisions of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA
Arterioscler Thromb Vasc Biol 25:365-71. 2005..PAI-1 inhibition significantly attenuated Ang II-induced aortic medial and wall thickening, but not cardiac hypertrophy, and enhanced Ang II/salt-induced cardiac fibrosis...
Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypassMias Pretorius
Veterans Affairs Medical Center and Department of Anesthesiology, and Division of Cardiovascular Medicine
Clin Pharmacol Ther 76:379-87. 2004..This study tested the hypothesis that angiotensin-converting enzyme (ACE) inhibitors potentiate activation of the kallikrein-kinin system during cardiopulmonary bypass (CPB)...
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal womenNancy J Brown
Division of Clinical Pharmacology, Department of Medicine, Vanerbilt University Medical Center, Nashville, Tennessee, USA
Circulation 105:304-9. 2002..Larger studies that use clinical outcomes are needed to determine whether PAI-1 4G/5G genotype should influence the choice of conjugated estrogens or ACE inhibition for the treatment of healthy postmenopausal women...
Uric acid and the state of the intrarenal renin-angiotensin system in humansTodd S Perlstein
Endocrinology, Diabetes and Hypertension Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Kidney Int 66:1465-70. 2004..The renal vascular response to exogenous angiotensin II (Ang II) provides an indirect measure of intrarenal RAS activity. We tested the hypothesis that the serum uric acid concentration predicts the renal vascular response to Ang II...
Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humansPairunyar Sawathiparnich
Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
J Clin Endocrinol Metab 87:448-52. 2002..57; P = 0.0003); however, treatment with spironolactone abolished this correlation (r(2) = 0.13; P = 0.33). This study provides evidence that endogenous aldosterone influences PAI-1 production in humans...
NO synthase inhibition increases aldosterone in humansJames A S Muldowney
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA
Hypertension 44:739-45. 2004..2 . [potassium]-28.9; r2=0.609; P=0.008) but not during vehicle (P=0.313). These data suggest that endogenous NO modulates aldosterone synthesis in humans...
Thyroid function and blood pressure homeostasis in euthyroid subjectsOlga Gumieniak
Endocrinology, Diabetes and Hypertension Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, RFB-2, Boston, MA 02115, USA
J Clin Endocrinol Metab 89:3455-61. 2004..These data show that the influence of thyroid function on blood pressure homeostasis extends into euthyroid range and likely reflects the action of thyroid hormone on peripheral vasculature...
Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedemaJean Lefebvre
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232 6602, USA
Hypertension 39:460-4. 2002..With respect to APP activity, there was no difference between groups. These results suggest that DPPIV activity is depressed in individuals with hypertension during acute ACEI-associated angioedema...
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitorsQing Ling Duan
Centre de Recherche du CHUM, Hopital Notre Dame, Montreal, Quebec, Canada
Am J Hum Genet 77:617-26. 2005..0364). In conclusion, our findings provide supporting evidence that the C-2399A variant in XPNPEP2 is associated with reduced APP activity and a higher incidence of AE-ACEi...
Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykininDavid A Rosenbaum
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn, USA
Arterioscler Thromb Vasc Biol 22:1023-8. 2002..037). These data suggest that the BK-dependent alterations in vascular fibrinolytic function are preserved in black Americans compared with white Americans...
Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edemaJames Brian Byrd
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
J Allergy Clin Immunol 120:403-8. 2007..ACE and DPPIV degrade substance P, an edema-forming peptide. The contribution of impaired degradation of substance P by DPPIV to the pathogenesis of ACE inhibitor-associated angioedema is unknown...
Angiotensin-converting enzyme inhibitor-associated angioedemaJames Brian Byrd
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 560 Robinson Research Building, Nashville, TN 37232-6602, USA
Immunol Allergy Clin North Am 26:725-37. 2006..Defective degradation of vasoactive peptide substrates of ACE, such as bradykinin or substance P, may contribute via non-ACE pathways to the pathogenesis of ACE inhibitor-associated angioedema...
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertensionLuminita Pojoga
Brigham and Women's Hospital, Division of Endocrinology, Diabetes, and Hypertension, 221 Longwood Ave, Boston, MA 02115, USA
Hypertension 48:892-900. 2006..Importantly, this association could only be detected with an intermediate and not a distant phenotype...
Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acidJames A S Muldowney
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 6300, USA
Thromb Haemost 97:263-71. 2007..These studies suggest that thrombin-stimulated t-PA release is Galphaq-, PLC-beta-, IP3-, and 5,6-EET-dependent while being prostacyclin-, NO- and K+ channel-independent in HMECs...
